Impact of withdrawal of fusafungine from the market on the prescribing of alternative treatments in Germany (Fusafungine impact study)

14/06/2018
12/03/2020
EU PAS number:
EUPAS24430
Study
Finalised
Documents
Study protocol
Initial protocol
English (62.58 KB - PDF) View document
Study results
Study report
Other information
Publications